Guangdong Marubi Biotechnology Co., Ltd.
- Jurisdiction
China - ISIN
CNE100003M51 (603983.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
8
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Guangdong Marubi Biotechnology Co., Ltd. provides eye care product in China. Read full profile
Fundamentals
- Net revenue
€402.95M - Gross margin
73.8% - EBIT
€47.28M - EBIT margin
11.7% - Net income
€41.74M - Net margin
10.4%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
CN¥0.50 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
145.5%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions